327 related articles for article (PubMed ID: 31928168)
1. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
[No Abstract] [Full Text] [Related]
2. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
3. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
[No Abstract] [Full Text] [Related]
4. Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.
Anagnostis P; Florou P; Bosdou JK; Grimbizis GF; Iakovou I; Kolibianakis EM; Goulis DG
Maturitas; 2021 Jun; 148():40-45. PubMed ID: 34024350
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
[No Abstract] [Full Text] [Related]
6. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
7. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
8. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.
Giusti M; Mittica M; Comite P; Campana C; Gay S; Mussap M
Endocrine; 2018 Jun; 60(3):516-523. PubMed ID: 29302874
[TBL] [Abstract][Full Text] [Related]
10. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal analysis of quality of life in patients treated for differentiated thyroid cancer.
van Velsen EFS; Massolt ET; Heersema H; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Eur J Endocrinol; 2019 Dec; 181(6):671-679. PubMed ID: 31639771
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Mizowaki T
Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.
Reiners C; Schneider R; Platonova T; Fridman M; Malzahn U; Mäder U; Vrachimis A; Bogdanova T; Krajewska J; Elisei R; Vaisman F; Mihailovic J; Costa G; Drozd V
Front Endocrinol (Lausanne); 2020; 11():381. PubMed ID: 32754115
[TBL] [Abstract][Full Text] [Related]
14. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract][Full Text] [Related]
15. Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.
Hu T; Meng Z; Zhang G; Jia Q; Tan J; Zheng W; Wang R; Li X; Liu N; Zhou P; Upadhyaya A
Medicine (Baltimore); 2016 Aug; 95(35):e4451. PubMed ID: 27583853
[TBL] [Abstract][Full Text] [Related]
16. Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer.
Mittica M; Dotto A; Comina M; Teliti M; Monti E; Giusti M
Thyroid Res; 2020; 13():1. PubMed ID: 31938042
[TBL] [Abstract][Full Text] [Related]
17. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
[TBL] [Abstract][Full Text] [Related]
18. Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such Patients.
Drozd V; Schneider R; Platonova T; Panasiuk G; Leonova T; Oculevich N; Shimanskaja I; Vershenya I; Dedovich T; Mitjukova T; Grelle I; Biko J; Reiners C
Front Endocrinol (Lausanne); 2020; 11():567385. PubMed ID: 33193085
[No Abstract] [Full Text] [Related]
19. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
[TBL] [Abstract][Full Text] [Related]
20. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Sawka AM; Lakra DC; Lea J; Alshehri B; Tsang RW; Brierley JD; Straus S; Thabane L; Gafni A; Ezzat S; George SR; Goldstein DP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):479-90. PubMed ID: 18284643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
